Nelipepimut-S, an advanced peptide-based immunotherapeutic intervention, has demonstrated significant efficacy within the biomedical sector as it pertains to breast cancer management. Acting with precision, it selectively engages HER2-positive malignancies, thereby amplifying and fortifying the immune system's retaliation against these deleterious cells.
CAT No: R2072
CAS No:160212-35-1
Synonyms/Alias:NELIPEPIMUT-S;Neuvax;160212-35-1;NeuVax vaccine;KIFGSLAFL;Nelipepimut-S [USAN];E75 peptide;UNII-7M0A29CD8B;7M0A29CD8B;DTXSID80166835;L-Leucine, L-lysyl-L-isoleucyl-L-phenylalanylglycyl-L-seryl-L-leucyl-L-alanyl-L-phenylalanyl-;(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[2-[[(2S)-2-[[(2S,3S)-2-[[(2S)-2,6-diaminohexanoyl]amino]-3-methylpentanoyl]amino]-3-phenylpropanoyl]amino]acetyl]amino]-3-hydroxypropanoyl]amino]-4-methylpentanoyl]amino]propanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoic acid;Nelipepimut-S (USAN);L-lysyl-L-isoleucyl-L-phenylalanylglycyl-L-seryl-L-leucyl-L-alanyl-L-phenylalanyl-L-leucine;Human receptor tyrosine-protein kinase erbB-2 (proto-oncogene Neu, tyrosine kinase- type cell surface receptor HER2, CD340)-(347-355)-peptide;Nelipepimut s;E75 HER2 peptide;E-75 PEPTIDE;10: PN: WO2015050181 SEQID: 10 claimed protein;CHEMBL386200;NELIPEPIMUT S [WHO-DD];DTXCID3089326;AHOKKYCUWBLDST-QYULHYBRSA-N;CHEBI:230310;Her2 369-377;BDBM50409332;AKOS040753235;DA-76075;E-75;HER-2/NEU PEPTIDE (369-377);HY-106204;CS-0025241;Q27268544;HUMAN RECEPTOR TYROSINE-PROTEIN KINASE ERBB-2 (PROTO-ONCOGENE NEU, TYROSINE KINASE-TYPE CELL SURFACE RECEPTOR HER2, CD340)-(347-355)-PEPTIDE;
Chemical Name:(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[2-[[(2S)-2-[[(2S,3S)-2-[[(2S)-2,6-diaminohexanoyl]amino]-3-methylpentanoyl]amino]-3-phenylpropanoyl]amino]acetyl]amino]-3-hydroxypropanoyl]amino]-4-methylpentanoyl]amino]propanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoic acid
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.